1. Home
  2. IKT vs PPIH Comparison

IKT vs PPIH Comparison

Compare IKT & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • PPIH
  • Stock Information
  • Founded
  • IKT 2008
  • PPIH 1993
  • Country
  • IKT United States
  • PPIH United States
  • Employees
  • IKT N/A
  • PPIH N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • PPIH Pollution Control Equipment
  • Sector
  • IKT Health Care
  • PPIH Industrials
  • Exchange
  • IKT Nasdaq
  • PPIH Nasdaq
  • Market Cap
  • IKT 131.6M
  • PPIH 112.6M
  • IPO Year
  • IKT 2020
  • PPIH N/A
  • Fundamental
  • Price
  • IKT $1.66
  • PPIH $20.70
  • Analyst Decision
  • IKT Buy
  • PPIH
  • Analyst Count
  • IKT 2
  • PPIH 0
  • Target Price
  • IKT $8.00
  • PPIH N/A
  • AVG Volume (30 Days)
  • IKT 126.7K
  • PPIH 55.1K
  • Earning Date
  • IKT 08-13-2025
  • PPIH 06-13-2025
  • Dividend Yield
  • IKT N/A
  • PPIH N/A
  • EPS Growth
  • IKT N/A
  • PPIH N/A
  • EPS
  • IKT N/A
  • PPIH 1.55
  • Revenue
  • IKT N/A
  • PPIH $170,810,000.00
  • Revenue This Year
  • IKT N/A
  • PPIH N/A
  • Revenue Next Year
  • IKT N/A
  • PPIH N/A
  • P/E Ratio
  • IKT N/A
  • PPIH $13.65
  • Revenue Growth
  • IKT N/A
  • PPIH 9.96
  • 52 Week Low
  • IKT $1.12
  • PPIH $7.72
  • 52 Week High
  • IKT $4.20
  • PPIH $23.17
  • Technical
  • Relative Strength Index (RSI)
  • IKT 35.43
  • PPIH 73.54
  • Support Level
  • IKT $1.91
  • PPIH $14.26
  • Resistance Level
  • IKT $2.07
  • PPIH $23.17
  • Average True Range (ATR)
  • IKT 0.11
  • PPIH 1.34
  • MACD
  • IKT -0.03
  • PPIH 0.78
  • Stochastic Oscillator
  • IKT 0.00
  • PPIH 75.18

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About PPIH Perma-Pipe International Holdings Inc.

Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.

Share on Social Networks: